BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 12184912)

  • 1. Increased expression of interleukin-18 receptor on T lymphocytes in patients with acute graft-versus-host disease after allogeneic bone marrow transplantation.
    Fujimori Y; Yoshimoto T; Matsui K; Tsutsui H; Okamoto T; Kashiwamura S; Hada T; Okamura H; Kakishita E; Hara H; Nakanishi K
    J Interferon Cytokine Res; 2002 Jul; 22(7):751-4. PubMed ID: 12184912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential upregulation of interleukin-18 receptor alpha chain between CD4+ and CD8+ T cells during acute graft-versus-host disease in mice.
    Itoi H; Fujimori Y; Tsutsui H; Matsui K; Hada T; Kakishita E; Okamura H; Hara H; Nakanishi K
    J Interferon Cytokine Res; 2004 May; 24(5):291-6. PubMed ID: 15153312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Difference in the expression of Fas/Fas-ligand and the lymphocyte subset reconstitution according to the occurrence of acute GVHD.
    Lee S; Chong SY; Lee JW; Kim SC; Min YH; Hahn JS; Ko YW
    Bone Marrow Transplant; 1997 Nov; 20(10):883-8. PubMed ID: 9404931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of interleukin-18 in acute graft-versus-host disease in mice.
    Itoi H; Fujimori Y; Tsutsui H; Matsui K; Sugihara A; Terada N; Hada T; Kakishita E; Okamura H; Hara H; Nakanishi K
    Transplantation; 2004 Nov; 78(9):1245-50. PubMed ID: 15548959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paradoxical effects of interleukin-18 on the severity of acute graft-versus-host disease mediated by CD4+ and CD8+ T-cell subsets after experimental allogeneic bone marrow transplantation.
    Min CK; Maeda Y; Lowler K; Liu C; Clouthier S; Lofthus D; Weisiger E; Ferrara JL; Reddy P
    Blood; 2004 Nov; 104(10):3393-9. PubMed ID: 15280194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The role of CD4+ CD25+ T cell and FOXP3 in hsot acute graft rejection].
    Liu YJ; Wu DP; Li CX; He J; Qiu QC; Zhang XG
    Zhonghua Nei Ke Za Zhi; 2006 Oct; 45(10):835-8. PubMed ID: 17217750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of bone marrow mesenchymal stem cells on acute graft versus host disease and graft versus leukemia after allogeneic bone marrow transplantation].
    Hu WB; Gao QP; Chen YH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Jun; 13(3):404-7. PubMed ID: 15972130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The role of third-party tolerogenic dendritic cells in the prevention of acute graft-versus-host-disease following allogeneic bone marrow transplantation in mice].
    Li GP; Yang J; Hao J; Yang YM; Ren YN; Xie RF; Fan HH; Qian KC
    Zhonghua Xue Ye Xue Za Zhi; 2012 Jun; 33(6):461-6. PubMed ID: 22967381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation.
    Edinger M; Hoffmann P; Ermann J; Drago K; Fathman CG; Strober S; Negrin RS
    Nat Med; 2003 Sep; 9(9):1144-50. PubMed ID: 12925844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Donor CD4+ T-cell production of tumor necrosis factor alpha significantly contributes to the early proinflammatory events of graft-versus-host disease.
    Ewing P; Miklos S; Olkiewicz KM; Müller G; Andreesen R; Holler E; Cooke KR; Hildebrandt GC
    Exp Hematol; 2007 Jan; 35(1):155-63. PubMed ID: 17198884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effect of neutralizing anti-IL-18α monoclonal antibody on a mouse model of acute graft-versus-host disease.
    Li X; Zhang C; Chen W; Pan B; Kong F; Zheng K; Tang R; Zeng L
    Oncol Rep; 2015 Oct; 34(4):2031-9. PubMed ID: 26252430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of interleukin 12 receptor (IL-12R) and IL-18R on CD4+ T cells from patients with rheumatoid arthritis.
    Aita T; Yamamura M; Kawashima M; Okamoto A; Iwahashi M; Yamana J; Makino H
    J Rheumatol; 2004 Mar; 31(3):448-56. PubMed ID: 14994387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Idiopathic pneumonia syndrome in mice after allogeneic bone marrow transplantation.
    Shankar G; Bryson JS; Jennings CD; Morris PE; Cohen DA
    Am J Respir Cell Mol Biol; 1998 Feb; 18(2):235-42. PubMed ID: 9476911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flow cytometric analysis of the graft-versus-Leukemia-effect after hematopoietic stem cell transplantation in mice.
    Schmidt F; Hilger N; Oelkrug C; Svanidze E; Ruschpler P; Eichler W; Boldt A; Emmrich F; Fricke S
    Cytometry A; 2015 Apr; 87(4):334-45. PubMed ID: 25717029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD161(+) T cells as predictive markers for acute graft-versus-host disease.
    Lee SE; Lim JY; Yoon JH; Shin SH; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Cho SG; Kim DW; Lee JW; Min WS; Min CK
    Biol Blood Marrow Transplant; 2015 Mar; 21(3):421-8. PubMed ID: 25543092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential capacities of CD4+, CD8+, and CD4-CD8- T cell subsets to express IL-18 receptor and produce IFN-gamma in response to IL-18.
    Tomura M; Maruo S; Mu J; Zhou XY; Ahn HJ; Hamaoka T; Okamura H; Nakanishi K; Clark S; Kurimoto M; Fujiwara H
    J Immunol; 1998 Apr; 160(8):3759-65. PubMed ID: 9558078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary T cell repertoire in patients with graft-versus-host disease following blood and marrow transplantation.
    Yurovsky VV; Cottler-Fox MH; Atamas SP; Shanholtz CB; Britt EJ; Sensenbrenner LL; White B
    Am J Hematol; 2001 Jan; 66(1):1-11. PubMed ID: 11426485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated interleukin (IL)-18 levels during acute graft-versus-host disease after allogeneic bone marrow transplantation.
    Fujimori Y; Takatsuka H; Takemoto Y; Hara H; Okamura H; Nakanishi K; Kakishita E
    Br J Haematol; 2000 Jun; 109(3):652-7. PubMed ID: 10886219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble interleukin-2 receptor concentration as a biochemical indicator for acute graft-versus-host disease after allogeneic bone marrow transplantation.
    Mathias C; Mick R; Grupp S; Duffy K; Harris F; Laport G; Stadtmauer E; Luger S; Schuster S; Wasik MA; Porter DL
    J Hematother Stem Cell Res; 2000 Jun; 9(3):393-400. PubMed ID: 10894361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The identification and characteristics of IL-22-producing T cells in acute graft-versus-host disease following allogeneic bone marrow transplantation.
    Zhao K; Zhao D; Huang D; Song X; Chen C; Pan B; Wu Q; Cao J; Yao Y; Zeng L; Xu K
    Immunobiology; 2013 Dec; 218(12):1505-13. PubMed ID: 23816304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.